Service de Néonatologie. Centre Hospitalier Universitaire Sud Réunion, BP 350, 97448 Saint-Pierre Cedex, La Réunion, France; Centre d'Etudes Périnatales Océan Indien (CEPOI), Centre Hospitalier Universitaire Sud Réunion, BP 350, 97448 Saint-Pierre cedex, La Réunion, France.
Department of Obstetrics & Gynaecology, University of Adelaide, Robinson Institute, Lyell McEwin Hospital, Australia.
J Reprod Immunol. 2017 Sep;123:72-77. doi: 10.1016/j.jri.2017.09.006. Epub 2017 Sep 18.
Eclampsia (together with epilepsy) being the first disease ever written down since the beginning of writings in mankind 5000 years ago, we will make a brief presentation of the different major steps in comprehension of Pre-eclampsia. 1) 1840. Rayer, description of proteinuria in eclampsia, 2) 1897 Vaquez, discovery of gestational hypertension in eclamptic women, 3) In the 1970's, description of the "double" trophoblastic invasion existing only in humans (Brosens & Pijnenborg,), 4) between the 1970's and the 1990's, description of preeclampsia being a couple disease. The "paternity problem" (and therefore irruption of immunology), 5) at the end of the 1980's, a major step forward: Preeclampsia being a global endothelial cell disease (glomeruloendotheliosis, hepatic or cerebral endotheliosis, HELLP, eclampsia), inflammation (J.Roberts.C Redman, R Taylor), 6) End of the 1990's: Consensus for a distinction between early onset preeclampsia EOP and late onset LOP (34 weeks gestation), EOP being rather a problem of implantation of the trophoblast (and the placenta), LOP being rather a pre-existing maternal problem (obesity, diabetes, coagulopathies etc…). LOP is predominant everywhere on this planet, but enormously predominant in developed countries: 90% of cases. This feature is very different in countries where women have their first child very young (88% of world births), where the fatal EOP (early onset) occurs in more than 30% of cases. 7) What could be the common factor which could explain the maternal global endotheliosis in EOP and LOP? Discussion about the inositol phospho glycans P type.
子痫(与癫痫一起)是人类有文字记载以来的 5000 年来记载的第一种疾病,我们将简要介绍对先兆子痫的不同主要认识步骤。1)1840 年。Rayer,子痫的蛋白尿描述,2)1897 年 Vaquez,子痫孕妇的妊娠高血压发现,3)在 20 世纪 70 年代,描述了仅存在于人类中的“双重”滋养细胞侵袭(Brosens 和 Pijnenborg),4)在 20 世纪 70 年代至 90 年代之间,描述了先兆子痫是一种夫妻疾病。“父亲问题”(因此免疫学的出现),5)在 20 世纪 80 年代末,迈出了重要的一步:先兆子痫是一种全身性内皮细胞疾病(肾小球内皮细胞病、肝或脑内皮细胞病、HELLP、子痫、炎症(J.Roberts.C Redman,R Taylor),6)20 世纪 90 年代末:区分早发型子痫前期 EOP 和晚发型子痫前期 LOP(34 周妊娠)的共识,EOP 更多的是滋养层植入的问题(胎盘),LOP 更多的是先前存在的母体问题(肥胖、糖尿病、凝血障碍等)。LOP 在这个星球上无处不在,但在发达国家极为普遍:90%的病例。在那些妇女很早(占世界出生人数的 88%)生育第一胎的国家,EOP(早发型)的致命病例超过 30%,这一特征非常不同。7)是什么因素可以解释 EOP 和 LOP 中母亲的全身性内皮细胞病?关于肌醇磷酸糖 P 型的讨论。